机构:[1]Department of Cardiopulmonary Bypass, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Cardiovascular Diseases, 100037 Beijing, China[2]Department of Anesthesiology and Translational Neuroscience Center, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, China四川大学华西医院[3]Department of Cardiovascular Surgery, Guangdong Provincial Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, 510080 Guangzhou, Guangdong, China[4]Department of Cardiac Surgery, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China[5]Department of Anesthesiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Cardiovascular Diseases, 100037 Beijing, China[6]Department of Cardiopulmonary Bypass, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China首都医科大学附属安贞医院[7]Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China首都医科大学附属安贞医院[8]Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, 100005 Beijing, China医技科室麻醉科首都医科大学附属北京同仁医院首都医科大学附属同仁医院
The Working Group on Cardiopulmonary Bypass and Extracorporeal Life Support of China National Center for Cardiovascular Quality Improvement presents evidence-based guidelines on patient blood management for adult cardiac surgery under cardiopulmonary bypass. These guidelines aim to promote patient blood management programs, reduce blood loss and allogeneic transfusion, and improve patient outcomes. The Guidelines Panel includes multidisciplinary experts. Based on prior investigation and the patient, intervention, comparison, outcome (PICO) principles, thirteen questions from four aspects were selected, including priming and fluid management during cardiopulmonary bypass, anticoagulation and monitoring during cardiopulmonary bypass, peri-cardiopulmonary bypass blood product infusion, and autologous blood infusion. Systemic reviews of the thirteen questions were performed through literature research. Recommendations were generated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system and reviewed and refined by all the Guideline Panel members. A total of 19 recommendations were finally approved after five expert meetings between 2023 and 2024. By implementing these recommendations, perfusionists and medical staff involved in cardiac surgery can optimize patient blood management, effectively decrease allogeneic blood transfusion rates, minimize perioperative bleeding, and ultimately improve the prognosis in adult patients undergoing cardiac surgery with cardiopulmonary bypass.
基金:
Chinese society of cardiothoracic and vascular anesthesiology Transfusion-Free Program (2022-5); the 1•3•5
Outstanding Development Program of West China Hospital
of Sichuan University (2017-120); National Key Research
and Development Program of China (2023YFC2410305);
National Key Clinical Specialty Development Program of
China (2021).
第一作者机构:[1]Department of Cardiopulmonary Bypass, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Cardiovascular Diseases, 100037 Beijing, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Yan Shujie,Zhou Li,Chen Chen,et al.2024 Guidelines on Patient Blood Management for Adult Cardiac Surgery Under Cardiopulmonary Bypass in China[J].REVIEWS IN CARDIOVASCULAR MEDICINE.2025,26(6):doi:10.31083/RCM31384.
APA:
Yan, Shujie,Zhou, Li,Chen, Chen,Teng, Yuan,Liu, Gang...&Ji, Bingyang.(2025).2024 Guidelines on Patient Blood Management for Adult Cardiac Surgery Under Cardiopulmonary Bypass in China.REVIEWS IN CARDIOVASCULAR MEDICINE,26,(6)
MLA:
Yan, Shujie,et al."2024 Guidelines on Patient Blood Management for Adult Cardiac Surgery Under Cardiopulmonary Bypass in China".REVIEWS IN CARDIOVASCULAR MEDICINE 26..6(2025)